Cancer Immunology, Immunotherapy

Cancer Immunol Immunother · ISSN (print) 0340-7004 · ISSN (e) 1432-0851 · 12 papers in corpus
observational 2026
doi:10.1007/s00262-026-04324-z ·PMID:41697393

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

observational 2024
doi:10.1007/s00262-024-03895-z ·PMID:39708120

UNLABELLED: Vaccination has been considered the most crucial defence against viral infections, including SARS-CoV-2. Numerous reports have demonstrated the effectiveness of the above vaccines in oncological patients. It has also been proven…

lab-animal 2024
doi:10.1007/s00262-023-03596-z ·PMID:38430256

BACKGROUND: Cervical cancer is a common malignant tumor in the female. Interleukin (IL)-17A is a proinflammatory factor and exerts a vital function in inflammatory diseases and cancers. M2 macrophage has been confirmed to promote tumor deve…

review 2024
doi:10.1007/s00262-024-03708-3 ·PMID:38832992

Ovarian cancer is one of the most lethal malignant tumors, characterized by high incidence and poor prognosis. Patients relapse occurred in 65-80% after initial treatment. To date, no effective treatment has been established for these patie…

observational 2021
doi:10.1007/s00262-020-02750-1 ·PMID:33136178

BACKGROUND: Paraneoplastic neurological syndromes (PNS) may coexist with ovarian or lung cancers. Some tumors coexisting with PNS are smaller and have a better prognosis than tumors without PNS. PNS may constitute an opportunity to observe …

review 2021
doi:10.1007/s00262-020-02831-1 ·PMID:33411080

INTRODUCTION: Endometriosis is a risk factor for low-grade serous, clear cell, and endometroid ovarian carcinoma. In both endometriosis and ovarian carcinoma, immunological factors are associated with clinical outcome. Chronic inflammation …

other 2015
doi:10.1007/s00262-014-1632-x ·PMID:25376541

Inflammation has been implicated in the initiation and progression of ovarian cancer (OC), the underlying mechanisms of which are still unclear. We hypothesized that the abnormal expression of Toll-like receptors (TLRs), which were potentia…

observational 2014
doi:10.1007/s00262-014-1579-y ·PMID:25038892

Mannose-Binding Lectin (MBL) is a serum pattern recognition molecule, able to activate complement in association with MASP proteases. Serum levels of MBL and MASP-2, activities of MBL-MASP complexes, single nucleotide polymorphisms of the M…

lab-animal 2013
doi:10.1007/s00262-013-1483-x ·PMID:24114144

The progesterone analog medroxyprogesterone acetate (MPA) is widely used as a hormone replacement therapy in postmenopausal women and as contraceptive. However, prolonged administration of MPA is associated with increased incidence of breas…

observational 2013
doi:10.1007/s00262-013-1445-3 ·PMID:23744477

Ficolins are serum pattern recognition molecules. They have opsonic properties and are able to activate complement via the lectin pathway. This paper reports investigations concerning ficolin-2 and ficolin-3 in ovarian cancer (OC). Their se…

other 2010
doi:10.1007/s00262-010-0825-1 ·PMID:20177675

Chronic infection and inflammation are among the most important factors contributing to cancer development and growth. Toll-like receptors (TLRs) are important families of pattern recognition receptors, which recognize conserved components …

other 2009
doi:10.1007/s00262-008-0516-3 ·PMID:18414853

PURPOSE: Inflammatory cells can both suppress and stimulate tumor growth, and the influence of inflammatory cells on clinical outcome has been the focus of many studies. The purpose of this study was to evaluate the effectiveness of the neu…